keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ATI-2341, pepducin targeting the C-X-C chemokine receptor type 4 (CXCR4), is an allosteric agonist activating the inhibitory heterotrimeric G protein (Gi) to promote inhibition of cAMP production and induce calcium mobilization.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 約5 days | ¥ 27,000 |
2 mg | 約5 days | ¥ 50,500 |
5 mg | 約5 days | ¥ 91,000 |
10 mg | 約5 days | ¥ 145,500 |
説明 | ATI-2341, pepducin targeting the C-X-C chemokine receptor type 4 (CXCR4), is an allosteric agonist activating the inhibitory heterotrimeric G protein (Gi) to promote inhibition of cAMP production and induce calcium mobilization. |
ターゲット&IC50 | CXCR4:194 nM(EC50) |
別名 | ATI2341 |
分子量 | 2256.82 |
分子式 | C104H178N26O25S2 |
CAS No. | 1337878-62-2 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 2 mg/mL (0.88 mM)
DMSO: 93 mg/mL (41.2 mM)
H2O: <1 mg/mL
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ATI-2341 1337878-62-2 Autophagy GPCR/G Protein Immunology/Inflammation CXCR Inhibitor inhibit ATI2341 ATI 2341 CXC chemokine receptors inhibitor